SCHEMBL29933389

SCHEMBL29933389

CC1(C)CCC(c2cccc(N)c2)C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DDB1 Q16531 4/20 0.41
CRBN Q96SW2 4/20 0.41
TRPA1 O75762 1/20 0.38
CYP3A4 P08684 1/20 0.35
CASP1 P29466 1/20 0.35
RECQL P46063 1/20 0.35
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA9 Q16790 1/20 0.34
ALDH1A1 P00352 2/20 0.34
KDM1A O60341 5/20 0.34
MAOA P21397 4/20 0.34
MAOB P27338 4/20 0.34
GAA P10253 1/20 0.34
ATP1A1 P05023 2/20 0.34
ATP1B1 P05026 2/20 0.34
ATP1A3 P13637 2/20 0.34
ATP1B2 P14415 2/20 0.34
ATP1A2 P50993 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23364721 1.00 DDB1 (0.41) DDB1CRBNTRPA1CYP3A4CASP1
SCHEMBL29932791 0.80 KDM1A (0.44) TRPA1ALDH1A1KDM1AATP1A1ATP1B1
SCHEMBL23364732 0.80 KDM1A (0.44) TRPA1ALDH1A1KDM1AATP1A1ATP1B1
SCHEMBL27545833 0.78 TRPA1 (0.58) TRPA1KDM1AMAOAMAOBATP1A1
SCHEMBL23364793 0.76 TRPA1 (0.39) TRPA1ALDH1A1KDM1AATP1A1ATP1B1
SCHEMBL29411064 0.76 CYP3A4 (0.50) DDB1CRBNCYP3A4CASP1RECQL
SCHEMBL273350 0.76 CYP3A4 (0.50) DDB1CRBNCYP3A4CASP1RECQL
SCHEMBL23713634 0.75 TRPA1 (0.41) DDB1CRBNTRPA1CYP3A4CASP1
SCHEMBL23258718 0.75 HDAC4 (0.45) TRPA1ATP1A1ATP1B1ATP1A3ATP1B2
SCHEMBL23250714 0.75 HDAC4 (0.45) TRPA1ATP1A1ATP1B1ATP1A3ATP1B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115003659-A 5-membered heteroaryl amino sulfonamides for the treatment of conditions mediated by a deficiency in CFTR activity 健赞公司 2022-09-02 CN disclosed